Patents Represented by Law Firm Pennie & Edmonds
  • Patent number: 6794177
    Abstract: A purified DNA polymerase exhibiting reverse transcriptase activity in the presence of magnesium ions and/or manganese ions having reduced or no 5′-3′-exonuclease activity and substantially no RNaseH activity and obtainable from Carboxydothermus hydrogenoformans.
    Type: Grant
    Filed: February 5, 2002
    Date of Patent: September 21, 2004
    Assignee: Roche Diagnostics GmbH
    Inventors: Ursula Markau, Christine Ebenbichler, Gunthar Achhammer, Waltraud Ankenbauer
  • Patent number: 6770134
    Abstract: A method of forming a planar waveguide structure, comprising forming a first graded layer on a substrate, wherein the first graded layer comprises a first and a second optical material, wherein the concentration of the first optical material increases with the height of the first graded layer; forming a second graded layer on the first graded layer, the second graded layer comprising the first and second optical materials wherein the concentration of the first optical material decreases with the height of the second graded layer. The method further including forming a uniform layer on the first graded layer, the uniform layer containing first and second optical materials wherein the first optical material concentration is constant.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: August 3, 2004
    Assignee: Applied Materials, Inc.
    Inventors: Dan Maydan, Arkadii V. Samoilov
  • Patent number: 6691041
    Abstract: The present invention concerns a method for the quantification of a target nucleic acid in a sample comprising the following steps: (i) determination of the amplification efficiency of the target nucleic acid under defined amplification conditions, (ii) amplification of the target nucleic acid contained in the sample under the same defined reaction conditions, (iii) measuring the amplification in real-time, (iv) quantification of the original amount of target nucleic acid in the sample by correction of the original amount derived from step (iii) with the aid of the determined amplification efficiency. The efficiency correction of PCR reactions according to the invention for the quantification of nucleic acids can be used for absolute quantification with the aid of an external or internal standard as well as for relative quantification compared to the expression of housekeeping genes.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: February 10, 2004
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Gregor Sagner, Karim Tabiti, Martin Gutekunst, Richie Soong
  • Patent number: 6658961
    Abstract: A shift manipulating apparatus for an automatic transmission is disclosed that transmits manipulating force from a shift lever to a manual valve to position the spool of a manual valve at identical places in ranges P and N. The apparatus comprises a shift lever to receive shift range selection manipulating force of a driver; a manual valve to control oil pressure of the automatic transmission; and a linkage unit for connecting the shift lever and the spool of the manual valve to enable the spool to identically form an interconnection state of ports according to pivot of the shift lever in ranges P and N.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: December 9, 2003
    Assignee: Hyundai Motor Company
    Inventor: Chang-Wook Lee
  • Patent number: 6646437
    Abstract: System and method for characterizing formation properties based on NMR measurements. NMR clay measurements of this invention distinguish between interstitial pore water and the water adsorbed by the clay minerals. The measurements can be used to determine the quantity of adsorbed water in different clays and correct previously available data obtained using conventional density and neutron porosity logs. A new petrophysical parameter wetness clay is defined as an intrinsic parameter for clays, and its value is computed for members of the smectite group of clays, such as montmorillonite. The wet clay values for the density, neutron logs based on the adsorbed water in clays are used to enhance the quality and accuracy of the overall log interpretation.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: November 11, 2003
    Assignee: Halliburton Energy Services, Inc.
    Inventors: Dattatraya V. Chitale, George R. Coates, Peter Ian Day, Richard F. Sigal
  • Patent number: 6610354
    Abstract: A plasma display panel including a low k dielectric layer. In one embodiment, the dielectric layer is comprises a fluorine-doped silicon oxide layer such as an SiOF layer. In another embodiment, the dielectric layer comprises a Black Diamond™ layer. In certain embodiments, a capping layer such as SiN or SiON is deposited over the dielectric layer.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: August 26, 2003
    Assignee: Applied Materials, Inc.
    Inventors: Kam S. Law, Quanyuan Shang, Takako Takehara, Taekyung Won, William R. Harshbarger, Dan Maydan
  • Patent number: 6458374
    Abstract: Methods and compositions are disclosed utilizing the optically pure (+)-isomer of bupropion to assist in smoking cessation, for treating smoking and nicotine addiction, and for treating pain, including, but not limited to, chronic pain, neuropathetic pain and reflex sympathetic dystrophy, and other disorders such as narcolepsy, chronic fatigue syndrome, fibromyalgia, seasonal affective disorder and premenstrual syndrome, while avoiding adverse affects associated with racemic bupropion.
    Type: Grant
    Filed: January 28, 1999
    Date of Patent: October 1, 2002
    Assignee: Sepracor, Inc.
    Inventors: John R. McCullough, Paul D. Rubin
  • Patent number: 6406973
    Abstract: The present invention relates to a transistor in a semiconductor device and method of manufacturing the same, more particularly to a new dual gate P+ salicide forming technology having an elevated channel and a source/drain using the selective SiGe epi-silicon growth technology.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: June 18, 2002
    Assignee: Hyundai Electronics Industries Co., Ltd.
    Inventor: Jung Ho Lee
  • Patent number: 6364404
    Abstract: The invention relates to a system for fitting a window into a bay, especially a window of a transport vehicle; the window is rapidly removable, especially to allow the evacuation of passengers in a vehicle. The window (1) is equipped, by bonding, with a frame (2), especially a metal frame, which itself is fixed to the body opening (3) by discrete mechanical fasteners (6). The latter are locked by systems which, for example, are unlocked from the inside of the vehicle. In one embodiment, the frame (16) is made of an elastomer and it has projections (17) on which locking members (18) bear.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: April 2, 2002
    Assignee: Saint-Gobain Vitrage
    Inventor: Martial De Paoli
  • Patent number: 6303358
    Abstract: The present invention relates to a newly identified family of protein serine/threonine kinases which phosphorylate microtubule-associated protein 2 (MAP2). It is based, in part, on the cloning and characterization of novel MAP2 kinases designated extracellular signal-regulated kinase 1, 2, and 3 (ERK1, ERK2, ERK3) which are expressed in the central nervous system, and on the identification of another ERK family member, ERK4, with antisera. The present invention provides for recombinant nucleic acid molecules and proteins representing members of the MAP2 kinase family, and also for microorganisms, transgenic animals, and cell lines comprising recombinant MAP2 kinase molecules. In additional embodiments of the invention, the present invention provides for methods for assaying cellular factor activity, including, but not limited to, nerve growth factor activity, in which the activation of MAP2 kinase serves as an indicator of cellular factor activity.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: October 16, 2001
    Assignees: Regeneron Pharmaceuticals, Inc., University of Texas
    Inventors: Teri G. Boulton, Melanie H. Cobb, George D. Yancopoulos, Steven Nye, Nikos Panayotatos
  • Patent number: 6297035
    Abstract: The present invention relates to a newly identified family of protein serine/threonine kinases which phosphorylate microtubule-associated protein 2 (MAP2). It is based, in part, on the cloning and characterization of novel MAP2 kinases designated extracellular signal-regulated kinase 1, 2, and 3 (ERK1, ERK2, ERK3) which are expressed in the central nervous system, and on the identification of another ERK family member, ERK4, with antisera. The present invention provides for recombinant nucleic acid molecules and proteins representing members of the MAP2 kinase family, and also for microorganisms, transgenic animals, and cell lines comprising recombinant MAP2 kinase molecules. In additional embodiments of the invention, the present invention provides for methods for assaying cellular factor activity, including, but not limited to, nerve growth factor activity, in which the activation of MAP2 kinase serves as an indicator of cellular factor activity.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: October 2, 2001
    Assignees: Regeneron Pharmaceuticals, Inc., University of Texas
    Inventors: Teri G. Boulton, Melanie H. Cobb, George D. Yancopoulos, Steven Nye, Nikos Panayotatos
  • Patent number: 6286364
    Abstract: A method and a system for measuring the spin decay rate of a golf ball. The system includes an indoor testing area, a launching device, and a measuring device positioned at a final position along the ball's flight path. When the ball is launched by the launching device, the measuring device measures the spin rate and speed at the final position. Then, the launching device can launch the ball at the speed and spin rate of the final position and a new final speed and spin rate are measured again. The spin rate difference from launching to the final position is used to determine the spin decay rate. By using discrete spin decay rate measurements, the spin decay rate profile of a golf ball during its entire flight can be measured in the indoor area.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: September 11, 2001
    Assignee: Acushnet Company
    Inventors: Steven Aoyama, William Gobush, Diane I. Pelletier, Charles A. Days, George Costa
  • Patent number: 6277963
    Abstract: The present invention relates to a newly identified family of protein serine/threonine kinases which phosphorylate microtubule-associated protein 2 (MAP2). It is based, in part, on the cloning and characterization of novel MAP2 kinases designated extracellular signal-regulated kinase 1, 2, and 3 (ERK1, ERK2, ERK3) which are expressed in the central nervous system, and on the identification of another ERK family member, ERK4, with antisera. The present invention provides for recombinant nucleic acid molecules and proteins representing members of the MAP2 kinase family, and also for microorganisms, transgenic animals, and cell lines comprising recombinant MAP2 kinase molecules. In additional embodiments of the invention, the present invention provides for methods for assaying cellular factor activity, including, but not limited to, nerve growth factor activity, in which the activation of MAP2 kinase serves as an indicator of cellular factor activity.
    Type: Grant
    Filed: September 18, 1997
    Date of Patent: August 21, 2001
    Assignees: Regeneron Pharmaceuticals, Inc., University of Texas
    Inventors: Teri G. Boulton, Melanie H. Cobb, George D. Yancopoulos, Steven Nye, Nikos Panayotatos
  • Patent number: 6210927
    Abstract: Novel peptide hormones which influence the release of gonadotropins by the pituitary gland in fish are disclosed. Methods in which such peptides may be administered to fish to control their reproduction are also described. Furthermore, novel isolated cDNA encoding the precursor of the novel gonadotropin-releasing hormone is disclosed. The use of such cDNA in controlling the gonadal development and spawning of fish is also described.
    Type: Grant
    Filed: June 30, 1997
    Date of Patent: April 3, 2001
    Assignee: University of Maryland Biotechnology Institute
    Inventors: Yonathan Zohar, Yoav Gothilf
  • Patent number: 6187795
    Abstract: Methods and compositions are disclosed utilizing metabolic derivatives of astemizole for the treatment of allergic disorders while avoiding the concomitant liability of adverse effects associated with the astemizole. The metabolic derivatives of astemizole are also useful for the treatment of retinopathy and other small vessel disorders associated with diabetes mellitus and such other conditions as may be related to the antihistamine activity of astemizole. For example, the metabolic derivatives of astemizole are useful for the treatment of asthma, motion sickness, and vertigo, without the concomitant liability of adverse effects associated with astemizole.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: February 13, 2001
    Assignee: Sepracor Inc.
    Inventors: Raymond L. Woosley, A. K. Gunnar Aberg
  • Patent number: 6181665
    Abstract: A volume holographic data storage (VHDS) system incorporates therein a storage device having a plurality of storage media for storing multiple holograms. The VHDS system comprises a light source for generating a coherent light beam, a beam splitter for splitting the coherent light beam into a reference and a signal beams, a storage device having a base and a plurality of storage media mounted on the base for three-dimensionally storing the multiple holograms thereinto, a pair of mirrors for directing the signal and the reference beams to the storage device, respectively, and a motor for rotating the storage device about an axis perpendicular to a plane which includes the signal and reference beams, wherein the axis passes through a center point of the storage device. In the storage device, each of the storage media is mounted on top of the base angularly separated by an angle of &bgr;degrees.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: January 30, 2001
    Assignee: Daewoo Electronics Co., Ltd.
    Inventor: Jae-Woo Roh
  • Patent number: 6143415
    Abstract: The invention relates to a bonding agent for PVDF, containing alkyl (alkyl)acrylate units and units bearing a carboxylic acid functional group. This bonding agent, containing PVDF, forms a barrier to hydrocarbons. The invention also relates to the material including the present bonding agent, especially petrol pipes including polyamide and the present bonding agent, in conjunction with PVDF.
    Type: Grant
    Filed: September 3, 1996
    Date of Patent: November 7, 2000
    Assignee: Elf Atochem S.A.
    Inventors: Serge Lorek, Philippe Bussi, Philippe Renouard
  • Patent number: 6140066
    Abstract: The present invention relates to methods for cancer diagnosis using a chimeric toxin. In particular, the invention relates to the use of a chimeric toxin composed of gonadotropin releasing hormone (GnRH) and Pseudomonas exotoxin A (PE) to detect a tumor-associated epitope expressed by human adenocarcinomas. Mutated GnRH-PE molecules that bind but do not kill tumor cells are exemplified.
    Type: Grant
    Filed: March 24, 1998
    Date of Patent: October 31, 2000
    Inventors: Haya Lorberboum-Galski, Shai Yarkoni, Ahmi Ben-Yehudah, Irina Marianovsky, Amotz Nechushtan
  • Patent number: 6113257
    Abstract: A container holding two separate components which are mixed prior to use is provided. The container comprises a housing with a dispensing opening and neck portion between said opening and the bottom end of housing. The container further comprises a displaceable member disposed within the housing and having a partition wall with an edge adapted for a sealing engagement with internal walls of the neck portion, thereby defining two compartments separated by said partition wall. A displaceable member is axially displaceable between two positions along an axis extending through the neck portion. These two positions comprise a first position where the edge of the partition wall sealingly engages the internal walls of the neck portion, and a second position where the edge of the partition wall and the internal walls are disengaged permitting flow communication between the two compartments. This flow communication allows mixing of the two components to form a formulation which is then ready for use.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: September 5, 2000
    Assignee: M.L.I.S. Projects Ltd.
    Inventors: Igal Sharon, Michael Inbar
  • Patent number: D477783
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: July 29, 2003
    Assignee: Texaco Inc.
    Inventors: Arthur Gilmore, Louis Lombardi, Klaus Rosburg